Bumetanide and Ingrowing nail - a phase IV clinical study of FDA data

Summary:

Ingrowing nail is reported as a side effect among people who take Bumetanide (bumetanide), especially for people who are female, 50-59 old, also take Metformin, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ingrowing nail when taking Bumetanide. It is created by eHealthMe based on reports of 20,353 people who have side effects when taking Bumetanide from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Ingrowing nail?

Ingrowing nail is found to be associated with 535 drugs and 408 conditions by eHealthMe. Check the latest studies of Ingrowing nail.

On Jul, 19, 2026

20,353 people reported to have side effects when taking Bumetanide.
Among them, 25 people (0.12%) have Ingrowing nail.

Among these 25 people:

What is the gender of people who have Ingrowing nail when taking Bumetanide? *

female: 100 %
male: 0.0 %

What is the age of people who have Ingrowing nail when taking Bumetanide? *

What are other drugs people take besides Bumetanide? *

What are other side effects people have besides Ingrowing nail? *

Tooth Disorder (tooth disease): 24 people, 96.00%
Skin Exfoliation (removal of the oldest dead skin cells): 24 people, 96.00%
Foot Fracture: 24 people, 96.00%
Cellulitis (infection under the skin): 24 people, 96.00%
Blister Infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 24 people, 96.00%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 24 people, 96.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 1 person, 4.00%
Renal Disorder (kidney disease): 1 person, 4.00%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 4.00%
Hypermetropia (abnormal condition in which vision for distant objects is better than for near objects): 1 person, 4.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 24 people, 96.00%
Blood Pressure Abnormal: 7 people, 28.00%
Depression: 5 people, 20.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Ingrowing nail?

- Check whether Ingrowing nail is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumetanide:

Bumetanide (20,532 reports)

Ingrowing nail treatments and more:

Ingrowing nail (3,607 reports)

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ingrowing nail:

Ingrowing nail (535 drugs)

Browse all the conditions that are associated with Ingrowing nail:

Ingrowing nail (408 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.